NO20035102D0 - Anvendelse av en gatran for fremstilling av et medikament for behandling avlunge fibrose - Google Patents
Anvendelse av en gatran for fremstilling av et medikament for behandling avlunge fibroseInfo
- Publication number
- NO20035102D0 NO20035102D0 NO20035102A NO20035102A NO20035102D0 NO 20035102 D0 NO20035102 D0 NO 20035102D0 NO 20035102 A NO20035102 A NO 20035102A NO 20035102 A NO20035102 A NO 20035102A NO 20035102 D0 NO20035102 D0 NO 20035102D0
- Authority
- NO
- Norway
- Prior art keywords
- gatran
- medicament
- manufacture
- treatment
- lung fibrosis
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 208000005069 pulmonary fibrosis Diseases 0.000 title abstract 2
- CDPROXZBMHOBTQ-SJORKVTESA-N 2-[[(2r)-3-cyclohexyl-1-[(2s)-2-[3-(diaminomethylideneamino)propylcarbamoyl]piperidin-1-yl]-1-oxopropan-2-yl]amino]acetic acid Chemical compound NC(N)=NCCCNC(=O)[C@@H]1CCCCN1C(=O)[C@H](NCC(O)=O)CC1CCCCC1 CDPROXZBMHOBTQ-SJORKVTESA-N 0.000 abstract 1
- 229950003291 inogatran Drugs 0.000 abstract 1
- 229960002137 melagatran Drugs 0.000 abstract 1
- DKWNMCUOEDMMIN-PKOBYXMFSA-N melagatran Chemical compound C1=CC(C(=N)N)=CC=C1CNC(=O)[C@H]1N(C(=O)[C@H](NCC(O)=O)C2CCCCC2)CC1 DKWNMCUOEDMMIN-PKOBYXMFSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101762A SE0101762D0 (sv) | 2001-05-18 | 2001-05-18 | New use |
| PCT/SE2002/000950 WO2002094304A1 (en) | 2001-05-18 | 2002-05-16 | The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20035102D0 true NO20035102D0 (no) | 2003-11-17 |
Family
ID=20284164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20035102A NO20035102D0 (no) | 2001-05-18 | 2003-11-17 | Anvendelse av en gatran for fremstilling av et medikament for behandling avlunge fibrose |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20040157772A1 (es) |
| EP (1) | EP1395277A1 (es) |
| JP (1) | JP2004529962A (es) |
| KR (1) | KR20040000460A (es) |
| CN (1) | CN1703234A (es) |
| BR (1) | BR0209578A (es) |
| CA (1) | CA2446049A1 (es) |
| IL (1) | IL158809A0 (es) |
| MX (1) | MXPA03010350A (es) |
| NO (1) | NO20035102D0 (es) |
| NZ (1) | NZ529345A (es) |
| SE (1) | SE0101762D0 (es) |
| WO (1) | WO2002094304A1 (es) |
| ZA (1) | ZA200308632B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7635707B1 (en) | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SA96170106A (ar) * | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
| AR005245A1 (es) * | 1995-12-21 | 1999-04-28 | Astrazeneca Ab | Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion |
| SE9601556D0 (sv) * | 1996-04-24 | 1996-04-24 | Astra Ab | New pharmaceutical formulation of a thrombin inhibitor for parenteral use |
| SE9704543D0 (sv) * | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
| SE9900070D0 (sv) * | 1999-01-13 | 1999-01-13 | Astra Ab | New use |
| AR023510A1 (es) * | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
-
2001
- 2001-05-18 SE SE0101762A patent/SE0101762D0/xx unknown
-
2002
- 2002-05-16 MX MXPA03010350A patent/MXPA03010350A/es unknown
- 2002-05-16 BR BR0209578-5A patent/BR0209578A/pt not_active IP Right Cessation
- 2002-05-16 EP EP02733707A patent/EP1395277A1/en not_active Withdrawn
- 2002-05-16 US US10/477,775 patent/US20040157772A1/en not_active Abandoned
- 2002-05-16 CN CNA028101073A patent/CN1703234A/zh active Pending
- 2002-05-16 KR KR10-2003-7014807A patent/KR20040000460A/ko not_active Withdrawn
- 2002-05-16 IL IL15880902A patent/IL158809A0/xx unknown
- 2002-05-16 NZ NZ529345A patent/NZ529345A/en unknown
- 2002-05-16 CA CA002446049A patent/CA2446049A1/en not_active Abandoned
- 2002-05-16 WO PCT/SE2002/000950 patent/WO2002094304A1/en not_active Ceased
- 2002-05-16 JP JP2002591021A patent/JP2004529962A/ja active Pending
-
2003
- 2003-11-05 ZA ZA200308632A patent/ZA200308632B/en unknown
- 2003-11-17 NO NO20035102A patent/NO20035102D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL158809A0 (en) | 2004-05-12 |
| WO2002094304A1 (en) | 2002-11-28 |
| CA2446049A1 (en) | 2002-11-28 |
| SE0101762D0 (sv) | 2001-05-18 |
| JP2004529962A (ja) | 2004-09-30 |
| EP1395277A1 (en) | 2004-03-10 |
| KR20040000460A (ko) | 2004-01-03 |
| BR0209578A (pt) | 2004-06-22 |
| CN1703234A (zh) | 2005-11-30 |
| MXPA03010350A (es) | 2004-03-16 |
| NZ529345A (en) | 2005-05-27 |
| ZA200308632B (en) | 2005-02-07 |
| US20040157772A1 (en) | 2004-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090281T1 (hr) | 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti | |
| NL300933I2 (nl) | Letermovir | |
| TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| CY1111693T1 (el) | Αντιιικοι παραγοντες | |
| ATE440603T1 (de) | 8-hydroxychinolinderivate | |
| NO20060847L (no) | Substituert 2-aminotetralin til behandling av depresjon | |
| DK1458360T3 (da) | Pulmonær afgivelse af aminoglycosider | |
| WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
| NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
| MXPA05005790A (es) | Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central. | |
| NO20013414D0 (no) | Ny anvendelse av melagatran | |
| SE0200198D0 (sv) | New use | |
| NO20044548L (no) | Fremgangsmate for fremstilling av 6-alkaliden-penemderivater | |
| MXPA04005809A (es) | Inhibidores de proteinas quinasas. | |
| ATE308540T1 (de) | Antithrombosemittel | |
| WO2008041134A3 (en) | Use of chlorine guanabenz derivatives for treating prion-based diseases | |
| NO20030297L (no) | Aryl sulfonamider som serotoninantagonist for behandling av fedme | |
| NO20032006D0 (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser | |
| NO20035102D0 (no) | Anvendelse av en gatran for fremstilling av et medikament for behandling avlunge fibrose | |
| ATE435853T1 (de) | Prostaglandinanaloga | |
| WO2004035031A3 (en) | Treatment of uveal melanoma | |
| DK1490049T3 (da) | Citalopram til behandling af forhöjet blodtryk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |